Unicycive Therapeutics, Inc. (UNCY)
Nasdaq: UNCY · Pharmaceutical Preparations · Los Altos, CA · filing with the SEC since 2019
Who owns Unicycive Therapeutics, Inc.
As filed with the SECHolders of 5% or more
5
Vivo Opportunity Fund Holdings, L.P. holds 9.99% of Common Stock, $0.001 par value per share, as its SCHEDULE 13G/A filed Aug 14, 2026 says.
Directors and officers
8
report now, of 10 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Vivo Opportunity Fund Holdings, L.P.
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.001 par value per share · 9.99% in Nov 14, 2025
Nantahala Capital Management, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.001 per share · 9.99% in Feb 13, 2026
Bvf Partners L P/il
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock, par value $0.001 per share
RA Capital Management, L.P.
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, $0.001 par value per share · 9.9% in Feb 17, 2026
Blackrock, Inc.
SCHEDULE 13G · filed Jul 30, 2026 · Common Stock
Walleye Capital LLC
SCHEDULE 13G/A · filed Feb 6, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%
Octagon Capital Advisors LP
SCHEDULE 13G/A · filed Feb 10, 2026 · Common Stock, $0.001 par value · reported falling below 5%, from 5.7% in Nov 14, 2025
Great Point Partners, LLC
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%, from 6.24% in Aug 14, 2025
Nantahala Capital Partners Limited Partnership
SCHEDULE 13G/A · filed Dec 20, 2024 · Common Stock, par value $0.001 per share · reported falling below 5%, from 7.76% in Nov 14, 2024
Millennium Management LLC
SCHEDULE 13G/A · filed Jul 8, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 5.5% in Jan 23, 2026
What UNCY reports owning in othersstakes of 5% or more, and other ties
Unicycive Therapeutics, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 29, 2025 to Oct 29, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
2022 runs to Oct 29, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.